Biognosys Newton, Massachusetts proteomics facility
IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-Quality Proteomic Insights
05. Dezember 2024 08:00 ET | Biognosys AG
IonOpticks and Biognosys announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys with custom chromatography columns.
Biognosys_Logo_Color.png
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
29. August 2024 08:27 ET | Biognosys AG
Biognosys Announces Commercial Availability of NULISA™ Proteomics Assay Services for Biomarker Research
Biognosys Newton, Massachusetts proteomics facility
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
30. Mai 2024 09:15 ET | Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics
Biognosys’ DIA mass spectrometry unbiased proteomics platform.png
Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
04. April 2024 08:11 ET | Biognosys AG
Collaboration brings together Biognosys’ expertise in DIA mass spectrometry and Alamar’s cutting-edge immunoassays to enhance understanding of biomarkers.
Biognosys Newton Entrance
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
23. Januar 2024 08:00 ET | Biognosys AG
Biognosys' new CRO facility for proteomics services in Newton, Massachusetts ensures closer proximity to US biopharma customers.
(un)Common Logic Logo.png
(un)Common Logic Introduces Conversion Optimization Rate Calculator
18. Januar 2024 09:00 ET | (un)Common Logic
Austin, Texas, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Austin-based digital marketing agency (un)Common Logic has announced a new tool for determining the potential revenue increase from optimizing a...
Inotiv_Logo_CMYK.png
Inotiv, Inc. to Report Fiscal 2023 Third Quarter Financial Results and Host Conference Call on Thursday, August 10, 2023
24. Juli 2023 16:35 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., July 24, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
FBI LOGO TM.png
Contract Research Organization Services Market Size to Surpass USD 188.52 Billion by 2030, exhibiting a CAGR of 12.5%
19. Juni 2023 08:06 ET | Fortune Business Insights
Pune, India, June 19, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, global Contract Research Organization Services Market size was valued at USD 73.38 billion in 2022 and is...
Inotiv_Logo_CMYK.png
Inotiv, Inc. to Participate in May Investor Conferences
19. Mai 2023 08:33 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., May 19, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
NMDP-BTM_Dual_2_Color_BlueGreen_Logo_RGB_2000x542 (1).png
The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® Mark Clinical Trials Day With New Resources and Services for Patients, Researchers, and Industry Sponsors
17. Mai 2023 08:12 ET | Be The Match
MINNEAPOLIS, May 17, 2023 (GLOBE NEWSWIRE) -- The National Marrow Donor Program® (NMDP)/Be The Match® and Be The Match BioTherapies® launched a new web resource page and free white paper, “Paving...